Cycloheptanol

Cycloheptanol

SCHEMBL5721974

N.N.O=C(O)c1ccc(C(=O)O)s1.OC1CCCCCC1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 6/20 0.44
PKM P14618 1/20 0.40
LIG1 P18858 1/20 0.40
TSHR P16473 2/20 0.39
RAB9A P51151 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
POLB P06746 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HPGD P15428 2/20 0.37
ALDH1A1 P00352 1/20 0.37
L3MBTL3 Q96JM7 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopentanol SCHEMBL5721961 0.98 DAO (0.45) DAOPKMLIG1TSHRRAB9A
Cyclooctanol SCHEMBL5302074 0.86 DAO (0.39) DAOPKMLIG1TSHRRAB9A
Cyclooctanol SCHEMBL5303490 0.81 RAB9A (0.60) RAB9AKMT2APOLBALDH1A1L3MBTL1
SCHEMBL28337958 0.78 DAO (0.45) DAORAB9AKMT2AMEN1POLB
SCHEMBL6420455 0.77 DAO (0.44) DAOPKMLIG1TSHRRAB9A
SCHEMBL70493 0.76 DAO (0.67) DAOPKMLIG1RAB9AKMT2A
Terephthalic Acid SCHEMBL27820027 0.75 SRD5A2 (0.58) TSHRRAB9AKMT2AALDH1A1SMN1; SMN2
SCHEMBL19987844 0.73 DAO (0.64) DAOPKMLIG1RAB9AKMT2A
SCHEMBL28353716 0.73 DAO (0.64) DAOPKMLIG1RAB9AKMT2A
Hydrochloric Acid SCHEMBL3074364 0.73 DAO (0.64) DAOPKMLIG1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6784173-B2 ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2004-08-31 US claimed
US-20030013757-A1 Aromatic dicarboxylic acid derivatives HOFFMANN-LA ROCHE INC. 2003-01-16 US claimed
EP-1401824-B1 AROMATIC HYDROXAMIC ACID DERIVATIVES USEFUL AS HDAC INHIBITORS HOFFMANN LA ROCHE (CH) 2006-10-25 EP disclosed
US-20040214862-A1 Aromatic dicarboxylic acid derivatives LESER-REIFF ULRIKE 2004-10-28 US disclosed
US-6784173-B2 ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2004-08-31 US disclosed
EP-1401824-A2 AROMATIC HYDROXAMIC ACID DERIVATIVES USEFUL AS HDAC INHIBITORS F. Hoffman-la Roche AG (CH) 2004-03-31 EP disclosed
WO-2003011851-A2 AROMATIC HYDROXAMIC ACID DERIVATIVES USEFUL AS HDAC INHIBITORS F. HOFFMAN-LA ROCHE AG (CH) 2003-02-13 WO disclosed
US-20030013757-A1 Aromatic dicarboxylic acid derivatives HOFFMANN-LA ROCHE INC. 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214862-A1 Aromatic dicarboxylic acid derivatives HDAC1, HDAC2, HDAC11 DAO 686/4885PKM 1284/4885LIG1 1889/4885
US-20030013757-A1 Aromatic dicarboxylic acid derivatives HDAC1, HDAC2, HDAC11 DAO 686/4885PKM 1284/4885LIG1 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.